PRESS RELEASE published on 11/14/2025 at 17:50, 20 days 12 hours ago NAV down 2.1% over 9 months, dividend included. Moderate activity in the third quarter after a busy start to the year Altamir reports NAV per share of €33.27 as of 30/09/2025, down 2.1% from 31/12/2024. Detailed performance insights and activities including divestments and investments over nine months Financial Report NAV Per Share Investments Divestments Altamir
BRIEF published on 11/14/2025 at 17:50, 20 days 12 hours ago Altamir's NAV fell by 2.1% over nine months Treasury Investments Transfers Commitments Revalued Net Asset Value
BRIEF published on 11/14/2025 at 17:50, 20 days 12 hours ago Baisse de l'ANR d'Altamir de 2,1% sur Neuf Mois Investissements Trésorerie Engagements Cessions Actif Net Réévalué
PRESS RELEASE published on 11/14/2025 at 17:45, 20 days 12 hours ago ANR d'Altamir en baisse de 2,1% sur 9 mois, dividende inclus. Activité modérée au 3ème trimestre, après un début d'année dynamique Altamir annonce un ANR par action de 33,27€ au 30/09/2025 avec une baisse de 2,1% depuis 31/12/2024. Détails sur l'évolution trimestrielle et les activités d'investissement et cession. Engagements financiers et faits marquants récents Cession Investissement Engagements ANR Altamir
PRESS RELEASE published on 09/18/2025 at 17:45, 2 months 16 days ago NAV down 1.3% in the first half of 2025, affected by exchange-rate movements. Investment activity resilient Altamir reports 1.3% decrease in NAV to €1,224.4 million at 30 June 2025, with a 0.5% increase at constant exchange rates. Portfolio EBITDA up 3.7%, led by resilient investment activity: €79.7M of disposals and €93.5M of investments made EBITDA NAV Investment Activity Altamir Portfolio Companies
BRIEF published on 09/18/2025 at 17:45, 2 months 16 days ago Altamir : Légère baisse de l'ANR impactée par les taux de change Investissements Résilience ANR Cessions Taux De Change
BRIEF published on 09/18/2025 at 17:45, 2 months 16 days ago Altamir: Slight drop in NAV impacted by exchange rates Investments Résilience Exchange Rate ANR Transfers
PRESS RELEASE published on 09/18/2025 at 17:40, 2 months 16 days ago ANR en recul de -1,3% sur le semestre, impacté par l'évolution des taux de change. Résilience de l'activité Au 30 juin 2025, l'ANR d'Altamir s'élève à 1 224,4M€, en baisse de 1,3% mais en hausse de +0,5% à taux de change constant. Resilience de l'activité avec 79,7M€ de cessions et 93,5M€ d'investissements Croissance Investissements ANR Cessions Altamir
PRESS RELEASE published on 09/12/2025 at 08:55, 2 months 22 days ago PRESS RELEASE REGARDING THE AVAILABILITY OF INFORMATION RELATING TO THE CHARACTERISTICS OF THE COMPANY IN THE CONTEXT OF THE SIMPLIFIED TENDER OFFER FOR THE ORDINARY SHARES OF ALTAMIR INITIATED BY AMBOISE SAS ALTAMIR publishes press release regarding AMF clearance decision for tender offer, providing legal, financial, and accounting information. Offer details and disclaimer included Financial Information AMF Tender Offer Regulations Altamir
BRIEF published on 09/12/2025 at 08:50, 2 months 22 days ago ALTAMIR : Mise à disposition de la Note en Réponse pour l'OPA simplifiée AMF Note En Réponse Altamir Amboise SAS OPA Simplifiée
Published on 12/05/2025 at 02:35, 4 hours 4 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 39 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 34 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 39 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 9 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 48 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 14 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 24 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 28 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 24 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL